Looking for a Sustiva attorney in District of Columbia? Get in touch with one of our Sustiva attorneys in District of Columbia now.
Sustiva - News Articles
-
Apr 19, 2007
Bizjournals.com, NC -
HIV drug maker Gilead Sciences Inc. reported growth in both revenue and profit for the first quarter ended March. The Foster City company (NASDAQ: GILD) reported a profit of $407.4 million for the quarter, compared with a first quarter profit of $262.7 million a ... -
Apr 19, 2007
Forbes, NY -
AP 04.19.07, 8:07 AM ET. Analysts were optimistic about Gilead Sciences Inc. Thursday after the biotech company reported a 55 percent jump in first-quarter profit on better-than-expected sales.Gilead's net income rose to $407.4 million, or 85 cents per share, from $262.7 million, or ... -
Apr 20, 2007
UK News, KY -
He acted as a technology transfer leader for Sustiva® tablet and contributed to the development of Cozaar/Hyzaar tablets. Throughout his career, he has ... -
Mar 27, 2007
Hindu, India -
Efavirenz, is the generic version of Bristol Myers Squibb's 'Sustiva', which helps in preventing the HIV virus from reproduction. It is also used in combination with other anti-retroviral agents for the treatment of HIV-infections and tuberculosis, Strides Arcolab ... -
Mar 27, 2007
Myiris.com, India -
Efavirenz, the generic version of Bristol Myers Squibb`s SUSTIVA, is a non nucleoside reverse transcriptase inhibitor which prevents the AIDS virus from reproducing in cells. Efavirenz is used in combination with other anti-retroviral agents for the treatment of HIV-infections and is ... -
Mar 28, 2007
Trading Markets, CA -
(RTTNews) - Wednesday, Strides Arcolab Ltd has announced that the company has received tentative approval from the US FDA for its Efavirenz tablets under the expedited review provisions of the President's Emergency Plan for Aids Relief program. Efavirenz, the generic version of Bristol ... -
Mar 28, 2007
Economic Times, India -
Efavirenz, is the generic version of Bristol Myers Squibb's 'Sustiva', which helps in preventing the HIV virus from reproduction. It is also used in combination withother anti-retroviral agents for the treatment of HIV-infections andtuberculosis, Strides Arcolab informed theBSE. ... -
Mar 29, 2007
San Francisco Chronicle, CA -
s HIV treatment drug, which is marketed as Sustiva, and clopidogrel, a drug marketed as Plavix by Bristol-Myers and Aventis SA to treat heart conditions. Thailand's health ministry said it will make generic versions of the drugs to distribute to people too poor to ... -
Mar 30, 2007
Kaiser network.org, DC -
Efavirenz is the generic version of Bristol-Myers Squibb's Sustiva ( PTI/The Hindu , 3/28). The drug is used in combination therapies, as well as in drug regiments for people on concurrent treatment for tuberculosis. Arun Kumar, Strides Arcolab's vice chair and managing director, said ... -
Mar 28, 2007
Moneycontrol.com (press release), India -
Efavirenz, the generic version of Bristol Myers Squibb’s SUSTIVA, is a non nucleoside reverse transcriptase inhibitor which prevents the AIDS virus from reproducing in cells. Efavirenz is used in combination with other anti-retroviral agents for the treatment of HIV-infections and is ...
-
Mar 28, 2007
Forbes, NY -
approval from the US Food and Drug Administration for Efavirenz tablets, a generic version of Bristol-Myers Squibb Co's SUSTIVA anti-AIDS drug. ... -
Mar 21, 2007
NAPWA, Australia -
A real-life example of this is the ‘2NN’ trial comparing the non-nucleosides efavirenz and nevirapine: looking at the results of this trial, you might notice that about 44 percent of participants taking nevirapine experienced treatment failure within 48 weeks, compared with ... -
Mar 23, 2007
Drug Newswire (press release), CT -
Rash and nervous system disorders were less frequent in the TMC278 groups, 8% and 33% respectively compared with 19% and 53% in the efavirenz group. Changes in lipids were more pronounced with efavirenz."The results from the Phase 2b study suggest that TMC278 may provide ... -
Mar 26, 2007
France24, France -
Some 100 AIDS activists on Monday rallied outside the Bangkok office of US pharmaceutical giant Abbott Laboratories over its decision to withdraw new ... -
Mar 26, 2007
Kaiser network.org, DC -
The decision by pharmaceutical company Abbott Laboratories to withdraw applications to sell new drugs in Thailand "certainly strikes at the heart of the government's efforts to secure life-saving medicine for all Thais," a Bangkok Post editorial says (Bangkok Post, 3/22). Abbott recently ... -
Mar 27, 2007
Javno.hr, Croatia -
French drugmaker Sanofi-Aventis has offered wider access to its heart disease medicine Plavix in Thailand. French drugmaker Sanofi-Aventis has offered wider access to its heart disease medicine Plavix in Thailand, where the army-backed government plans to make a generic version ... -
Mar 27, 2007
Medical News Today (press release), UK -
The American Medical Student Association (AMSA) stands in solidarity with Thai colleagues in their national day of action protesting Abbott's alarming ... -
Mar 26, 2007
Nature.com (subscription), UK -
Is there ever a good enough reason to deny life-saving medicines to an entire country's citizens? I say no. But it seems pharmaceutical giant Abbott begs to differ.The Chicago-based company decided on 14 March not to introduce in Thailand any of its seven new drugs — ... -
Mar 27, 2007
Reuters AlertNet, UK -
BANGKOK, March 27 (Reuters) - French drugmaker Sanofi-Aventis has offered wider access to its heart disease medicine Plavix in Thailand, where the army-backed government plans to make a generic version of the drug, the company said on Tuesday. ... -
Wednesday, March 28, 2007
Kaiser network.org, DC -
The Thai government and international pharmaceutical companies have failed to reach an agreement in recent talks over compulsory licenses issued by the country for certain medications, the Bangkok Post reports (Bangkok Post, 3/27). Pharmaceutical company Abbott Laboratories recently announced that it ...
Looking for a Sustiva attorney in District of Columbia? Get in touch with one of our Sustiva attorneys in District of Columbia now.
Pages: Previous 1 2 3 4 5 6 7 8 9 10 11 ... Next
These articles are related to: Sustiva Claim, Sustiva Lawsuit, Sustiva Law Suit, Sustiva Law Firm, Sustiva Lawyer, Sustiva Attorney, Sustiva Side Effects Symptoms, Sustiva Trial, Sustiva Verdict, Sustiva News, Sustiva Information, Sustiva Recall Lawyers, Sustiva Warning, Sustiva Class Action, Sustiva Prescription Drug, Sustiva Medication, Sustiva Drugs, Efavirenz Claim, Efavirenz Lawsuit, Efavirenz Law Suit, Efavirenz Law Firm, Efavirenz Lawyer, Efavirenz Attorney, Efavirenz Side Effects Symptoms, Efavirenz Trial, Efavirenz Verdict, Efavirenz News, Efavirenz Information, Efavirenz Recall Lawyers, Efavirenz Warning, Efavirenz Class Action, Efavirenz Prescription Drug, Efavirenz Medication, Efavirenz Drugs
